Kidney Cancer
Conditions
Keywords
Urology, Robotic surgery, Haemostasis, Partial Nephrectomy
Brief summary
The purpose of the study is to set up the larger prospective study on robotic partial nephrectomy, to describe the characteristics of patients operated for kidney cancer by this surgical procedure and also to determine the modalities of hemostasis in this procedure.
Detailed description
The primary objective of the study is to describe the characteristics of patients operated for kidney cancer by a robotic partial nephrectomy in France (recruiting centers, patient profile, tumor characteristics). Secondary Objective(s): 1. To describe the surgical techniques and operative development. 2. To assess the modalities of haemostasis, during robotic partial nephrectomy. 3. To assess peri-operative morbidity in robotic partial nephrectomy and post-operative complications. 4. To assess the outcome of renal function after a robotic partial nephrectomy. This study is a national, multicenter, prospective, cohort.
Interventions
PROCEDURERobotic partial surgery
Robotic partial surgery
Sponsors
University Hospital, Bordeaux
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject is at least 18 years old at the time of screening * Subject has been diagnosed with renal tumor(s) * Subject will undergo a robot assisted partial nephrectomy * Subject is willing and able to comply with the requirements of the protocol
Exclusion criteria
None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Post-operative complications evaluated according to the Clavien criteria | From surgery until 1 year of follow up | Per and post-operative transfusion rates |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Renal function after robotic partial nephrectomy measured by biological parameters | Follow-up during 12 months | Creatininemia |
| Per-operative modalities of haemostasis procedure | At Surgery | Haemostasis procedure |
| Per-operative modalities of haemostatic agent | At Surgery | Haemostatic agent |
Countries
France
Outcome results
None listed